Related Experiment Videos
Inflammatory Bowel Disease Is Associated With an Increased Risk of End-Stage Renal Disease: A Population-Based Cohort
Onuma Sattayalertyanyong1,2, Zoann Nugent2,3, Bryce Barr3
1Division of Gastroenterology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Background:
Inflammatory bowel disease (IBD) is associated with renal complications, but population-based data on end-stage renal disease (ESRD) are limited.
Aim:
To evaluate the incidence of ESRD and renal transplantation in IBD compared with the general population and to identify predictive factors associated with ESRD in the IBD population.
Methods:
This was a retrospective population-based cohort study using the University of Manitoba IBD Epidemiology Database linked to administrative healthcare data from 1984 to 2023 (12,639 IBD patients matched with 126,180 controls). ESRD was defined as requiring any two claims for outpatient dialysis within a 1-year period. Predictive factors were identified using proportional hazard regression and nested case-control logistic regression analyses.
Results:
IBD patients had a significantly higher incidence of dialysis (1.48% vs. 0.82%, p < 0.0001) and kidney transplantation (0.25% vs. 0.10%, p < 0.0001) than controls. IBD was an independent predictor of ESRD (HR = 1.53, 95% CI 1.23-1.90), with stronger associations in CD (HR = 1.93, 95% CI 1.39-2.68) than UC (HR = 1.28, 95% CI 0.96-1.72). Traditional risk factors including diabetes (HR = 3.82, 95% CI 3.22-4.53), hypertension (HR = 1.91, 95% CI 1.58-2.30), and congestive heart failure (HR = 6.37, 95% CI 5.25-7.72) remained strongly predictive. Within the IBD population, oral steroid treatment (OR = 2.0, 95% CI 1.06-3.81), allopurinol use (OR = 4.06, 95% CI 1.49-11.1) and bowel surgery (OR = 2.77, 95% CI 1.51-5.09) significantly predicted dialysis initiation.
Conclusions:
Persons with IBD have an increased risk of ESRD by nearly 50%, with CD showing a greater risk than UC. Bowel surgery, allopurinol use and oral steroid therapy are important predictors, emphasising the necessity of careful renal monitoring in IBD patients.
Related Concept Videos
01:25Inflammatory Bowel Disease III: Crohn's Disease
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
01:30Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
01:26Inflammatory Bowel Disease I: Introduction
01:20Inflammatory Bowel Disease II: Ulcerative Colitis
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...